Clinical Trial Update: IMmune Proteomics to Predict neoAdjuvant Chemotherapy and immunoTherapy Response in Gastric Cancer

View source ↗

Summary

Clinical trial investigating immune proteomics to predict response to neoadjuvant chemotherapy and immunotherapy in gastric cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Gastric Cancer, Gastroesophageal Junction Cancer | Status: RECRUITING